The meeting is cosponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the American Head & Neck Society (AHNS) and the Society for Immunotherapy of Cancer (SITC).
The symposium will feature interactive and case-based discussions that address new multidisciplinary therapies, treatment guidelines, supportive care and disparities in the treatment of head and neck cancer. Highlighted sessions include:
Two plenary sessions featuring clinical trials reports and studies from medical, surgical and radiation oncologists
Keynote discussions on increasing diversity in clinical trials and the evolving role of immunotherapy for head and neck cancers
Panels on topics such as new therapies for recurrent disease, improving survivorship care for patients, and AI and other emerging clinical decision support tools
